|
|
|
|
Vol. 59, Issue 2, 183-192, February 2001
Department of Biological Sciences, Murray State University, Murray,
Kentucky
The roots from Aconitum sp. plants have long been used
in Chinese herbal medicine for treating pain and various heart
conditions. The principal component of Aconitum remedies
is usually aconitine, a site 2 neurotoxin that may induce severe
neurological symptoms and cardiovascular collapse. Some
Aconitum species also contain lappaconitine, the
structure of which is remarkably similar to that of aconitine. In
contrast to aconitine, a sodium channel agonist, lappaconitine
reportedly blocks voltage-gated sodium channels in heart tissue. The
results in the present study demonstrate that lappaconitine blocks
cloned human heart (hH1) sodium channels under whole-cell,
voltage-clamp conditions. Lappaconitine binding has several
characteristics in common with the binding of site 2 neurotoxins, such
as aconitine and batrachotoxin. For example, lappaconitine binds almost
exclusively to open channels, but has little affect on resting or
inactivated channels. Moreover, lappaconitine binding is inhibited by
bupivacaine, a tertiary amine local anesthetic. Whereas site 2 neurotoxins often irreversibly modify channel kinetics, lappaconitine
irreversibly blocks the channels. Finally, channels containing lysine
substitutions within the local anesthetic receptor region at residues
F1760 or N1765 are resistant to block by bupivacaine or lappaconitine.
Given that site 2 neurotoxins and local anesthetics have nonidentical
but overlapping binding regions, these data suggest that lappaconitine
irreversibly blocks hH1 channels by binding to the site 2 receptor.
This article has been cited by other articles:
![]() |
W. Ulbricht Sodium Channel Inactivation: Molecular Determinants and Modulation Physiol Rev, October 1, 2005; 85(4): 1271 - 1301. [Abstract] [Full Text] [PDF] |
||||